American Journal of Neuroradiology, Vol 18, Issue 2 203-218, Copyright © 1997 by American Society of Neuroradiology
ARTICLES |
Multivoxel proton MR spectroscopy and hemodynamic MR imaging of childhood brain tumors: preliminary observations
AA Tzika, S Vajapeyam and PD Barnes
Department of Radiology, Children's Hospital, Boston, Mass 02115, USA.
PURPOSE: To assess multivoxel proton MR spectroscopy combined with MR imaging and hemodynamic MR imaging in the evaluation of brain tumors in children and young adults. METHODS: Fifteen patients with brain tumors and 10 healthy children underwent MR imaging and MR spectroscopy on a 1.5-T system. Ten patients with tumors had both MR spectroscopy and hemodynamic MR imaging. MR spectroscopy data sets with 1 cm3 to 3.4 cm3 resolution were acquired within 8.5 minutes by using a point-resolved spectroscopic, chemical-shift imaging technique in two dimensions with volume preselection. MR imaging was performed using fast spin-echo techniques. Hemodynamic MR imaging data were acquired every 2.5 seconds at one anatomic level using a spoiled gradient-echo sequence during intravenous bolus administration of contrast material. RESULTS: Assessment with multivoxel MR spectroscopy and hemodynamic MR imaging added about 30 minutes to the total MR examination time. Normal tissue exhibited spectral peaks from biologically significant compounds such as N-acetylaspartate (NAA), choline-containing compounds (Cho), and total creatine (tCr). Twelve biopsy-proved tumors exhibited prominent Cho, reduced NAA, variable tCr, and/or lactate or lipids, and two showed increased hemodynamic parameters. Three of the tumors treated with radiation did not reveal prominent levels of Cho. Tissue necrosis had no Cho, NAA, or tCr, and reduced hemodynamics. CONCLUSIONS: Preliminary findings by MR spectroscopy combined with MR imaging and hemodynamic MR imaging suggest that regions of active tumor may be differentiated from areas of normal tissue and areas of necrosis. These findings may enable metabolic and hemodynamic characterization of childhood brain tumors as well as suggest their response to therapy.
This article has been cited by other articles:
 |
|
 |
|
  W. Kulak, W. Sobaniec, J. Smigielska-Kuzia, B. Kubas, B. Zawada, and D. Otapowicz An Age and Gender Dependency of Metabolite Concentrations in Basal Ganglia in Children with Spastic Diplegia: Proton Magnetic Resonance Spectroscopy Study J Child Neurol, January 1, 2009; 24(1): 73 - 79. [Abstract] [PDF]
|
|
|
|
 |
|
 M. V. Spampinato, J. K. Smith, L. Kwock, M. Ewend, J. D. Grimme, D. L. A. Camacho, and M. Castillo Cerebral Blood Volume Measurements and Proton MR Spectroscopy in Grading of Oligodendroglial Tumors Am. J. Roentgenol., January 1, 2007; 188(1): 204 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Astrakas, D. Zurakowski, A. A. Tzika, M. K. Zarifi, D. C. Anthony, U. De Girolami, N. J. Tarbell, and P. M. Black Noninvasive Magnetic Resonance Spectroscopic Imaging Biomarkers to Predict the Clinical Grade of Pediatric Brain Tumors Clin. Cancer Res., December 15, 2004; 10(24): 8220 - 8228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lindskog, C. Spenger, J. Jarvet, A. Graslund, and P. Kogner Predicting Resistance or Response to Chemotherapy by Proton Magnetic Resonance Spectroscopy in Neuroblastoma J Natl Cancer Inst, October 6, 2004; 96(19): 1457 - 1466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Warren NMR Spectroscopy and Pediatric Brain Tumors Oncologist, June 1, 2004; 9(3): 312 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Law, S. Yang, H. Wang, J. S. Babb, G. Johnson, S. Cha, E. A. Knopp, and D. Zagzag Glioma Grading: Sensitivity, Specificity, and Predictive Values of Perfusion MR Imaging and Proton MR Spectroscopic Imaging Compared with Conventional MR Imaging AJNR Am. J. Neuroradiol., November 1, 2003; 24(10): 1989 - 1998. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. Sokol, D. W. Dunn, M. Edwards-Brown, and J. Feinberg Hydrogen Proton Magnetic Resonance Spectroscopy in Autism: Preliminary Evidence of Elevated Choline/Creatine Ratio J Child Neurol, April 1, 2002; 17(4): 245 - 249. [Abstract] [PDF]
|
|
|
|
|
|
A. A. Tzika, M. K. Zarifi, L. Goumnerova, L. G. Astrakas, D. Zurakowski, T. Young-Poussaint, D. C. Anthony, R. M. Scott, and P. McL. Black Neuroimaging in Pediatric Brain Tumors: Gd-DTPA-enhanced, Hemodynamic, and Diffusion MR Imaging Compared with MR Spectroscopic Imaging AJNR Am. J. Neuroradiol., February 1, 2002; 23(2): 322 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Dowling, A. W. Bollen, S. M. Noworolski, M. W. McDermott, N. M. Barbaro, M. R. Day, R. G. Henry, S. M. Chang, W. P. Dillon, S. J. Nelson, et al. Preoperative Proton MR Spectroscopic Imaging of Brain Tumors: Correlation with Histopathologic Analysis of Resection Specimens AJNR Am. J. Neuroradiol., April 1, 2001; 22(4): 604 - 612. [Abstract] [Full Text]
|
|
|
|
|
|
T. Kadota, T. Horinouchi, and C. Kuroda Development and Aging of the Cerebrum: Assessment with Proton MR Spectroscopy AJNR Am. J. Neuroradiol., January 1, 2001; 22(1): 128 - 135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Warren, J. A. Frank, J. L. Black, R. S. Hill, J. H. Duyn, A. A. Aikin, B. K. Lewis, P. C. Adamson, and F. M. Balis Proton Magnetic Resonance Spectroscopic Imaging in Children With Recurrent Primary Brain Tumors J. Clin. Oncol., March 1, 2000; 18(5): 1020 - 1020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. Burtscher, G. Skagerberg, B. Geijer, E. Englund, F. Stahlberg, and S. Holtas Proton MR Spectroscopy and Preoperative Diagnostic Accuracy: An Evaluation of Intracranial Mass Lesions Characterized by Stereotactic Biopsy Findings AJNR Am. J. Neuroradiol., January 1, 2000; 21(1): 84 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Law, S. Cha, E. A. Knopp, G. Johnson, J. Arnett, and A. W. Litt High-Grade Gliomas and Solitary Metastases: Differentiation by Using Perfusion and Proton Spectroscopic MR Imaging Radiology, March 1, 2002; 222(3): 715 - 721. [Abstract] [Full Text] [PDF]
|
|